1921
Volume 94, Issue 4
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract

Chagas disease, caused by the parasite , can cause a potentially life-threatening cardiomyopathy in approximately 10–40% of afflicted individuals. The decline in cardiac function characteristically progresses over the course of many years. We report a case of Chagas disease in which the patient experienced an atypical rapid deterioration to severe cardiomyopathy over the course of 16 months. This case argues the need for increased routine surveillance for patients with confirmed infection, who are determined to be at high-risk for worsening cardiomyopathy.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.15-0616
2016-04-06
2017-09-19
Loading full text...

Full text loading...

/deliver/fulltext/14761645/94/4/894.html?itemId=/content/journals/10.4269/ajtmh.15-0616&mimeType=html&fmt=ahah

References

  1. Punukollu G, Gowda R, Khan I, , 2007. Clinical aspects of the Chagas' heart disease. Int J Cardiol 115: 279283.[Crossref]
  2. Bern C, Kjos S, Yabsley MJ, Montgomery SP, , 2011. Trypanosoma cruzi and Chagas' disease in the United States. Clin Microbiol Rev 24: 655681.[Crossref]
  3. Rassi A, Jr Rassi A, Rassi S, , 2007. Predictors of mortality in chronic chagas disease: a systematic review of observational studies. Circulation 115: 11011108.[Crossref]
  4. Klein N, Hurwitz I, Durvasula R, , 2012. Globalization of Chagas disease: a growing concern in nonendemic countries. Epidemiol Res Int 2012: 113.[Crossref]
  5. Prata A, , 2001. Clinical and epidemiological aspects of Chagas disease. Lancet Infect Dis 1: 9299.[Crossref]
  6. Higuchi M, Benvenuti L, Reis M, , 2003. Pathophysiology of the heart in Chagas' disease: current status and new developments. Cardiovasc Res 60: 96107.[Crossref]
  7. Rassi A, Rassi A, Marin-Neto JA, , 2010. Chagas disease. Lancet 375: 13881402.[Crossref]
  8. Ribeiro AL, Rocha MO, , 1998. Indeterminate form of Chagas disease: considerations about diagnosis and prognosis. Rev Soc Bras Med Trop 31: 301.[Crossref]
  9. Biolo A, Ribeiro A, Clausell N, , 2010. Chagas cardiomyopathy—where do we stand after a hundred years? Prog Cardiovasc Dis 52: 300316.[Crossref]
  10. Viotti RJ, Vigliano C, Laucella S, Lococo B, Petti M, Bertocchi G, Ruiz Vera B, Armenti H, , 2004. Value of echocardiography for diagnosis and prognosis of chronic Chagas disease cardiomyopathy without heart failure. Heart 90: 655660.[Crossref]
  11. Chatterjee K, Zhang J, Honbo N, Karliner J, , 2010. Doxorubicin cardiomyopathy. Cardiology 115: 155162.[Crossref]
  12. Piano MR, , 2002. Alcoholic cardiomyopathy: incidence, clinical characteristics, and pathophysiology. Chest 121: 16381650.[Crossref]
  13. Viotti R, Vigliano C, Lococo B, , 2006. Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment. Ann Intern Med 144: 724734.[Crossref]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.15-0616
Loading
/content/journals/10.4269/ajtmh.15-0616
Loading

Data & Media loading...

  • Received : 21 Aug 2015
  • Accepted : 17 Nov 2015

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error